Cargando…
Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
BACKGROUND: A large proportion of patients with inflammatory bowel disease (IBD) relapse after drug discontinuation despite achieving a stable state of infliximab-induced clinical remission. Resuming the use of the same tumor necrosis factor-alpha (TNF-α) inhibitors in patients who relapse following...
Autores principales: | Yang, Seungwon, Yang, Siyoung, Kwon Jo, Young, Kim, Seungyeon, Jung Chang, Min, Choi, Junjeong, Hee Cheon, Jae, Yu, Yun Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438941/ https://www.ncbi.nlm.nih.gov/pubmed/34729142 http://dx.doi.org/10.1177/20406223211041927 |
Ejemplares similares
-
Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
por: Yang, Hua-Hua, et al.
Publicado: (2022) -
Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
por: Pan, Ran, et al.
Publicado: (2022) -
Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis
por: Deng, Linghui, et al.
Publicado: (2018) -
MicroRNAs as potential biomarkers for the diagnosis of inflammatory
bowel disease: a systematic review and meta-analysis
por: Sun, Lina, et al.
Publicado: (2022) -
Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
por: Dai, Yun-Kai, et al.
Publicado: (2020)